NCT00029185 is a NA clinical trial of Dehydrex in Corneal Diseases, sponsored by Holles Laboratories, Inc..

Who is sponsoring NCT00029185?

NCT00029185 is sponsored by Holles Laboratories, Inc..

What drugs are being tested in NCT00029185?

Interventions in NCT00029185: Dehydrex.

What condition does NCT00029185 study?

NCT00029185 studies Corneal Diseases, Recurrence.

Is NCT00029185 still recruiting?

NCT00029185 is currently completed. Last updated 24 March 2015.

Last reviewed 2015-03-24 · How we verify

NCT00029185

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Topical Dehydrex in Treating Recurrent Corneal Erosion

Completed NA Last updated 24 March 2015

What this trial tests

NA trial testing Dehydrex in Corneal Diseases in 300 participants. Completed in 1 September 2007.

Timeline

1 September 2001

1 September 2007

Quick facts

Lead sponsor	Holles Laboratories, Inc.
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	single group
Masking	double
Primary purpose	treatment
Enrollment	300
Start date	1 September 2001
Estimated completion	1 September 2007
Sites	1 location across United States

Drugs / interventions tested

Dehydrex — full drug profile →

Conditions studied

Corneal Diseases — all drugs for Corneal Diseases →
Recurrence — all drugs for Recurrence →

Sponsor

Holles Laboratories, Inc. — full company profile →

Who can join

18 and older, any sex, with Corneal Diseases or Recurrence. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a compassionate-use treatment study to provide Dehydrex to patients with corneal erosion syndrome who have previously used Dehydrex.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Corneal Diseases

Currently open trials in the same condition.

NCT07149740 — Data Gathering for A10900 · recruiting
NCT06983652 — Validation of the Use of Terahertz Scanning System on Corneal Scars and Corneal Edema · recruiting
NCT06967792 — Evaluation of the Safety of Terahertz Scanning System on Corneas · recruiting
NCT06451172 — Novel Antisense Oligonucleotide Eye Drops for Treating Antibiotic-Resistant Bacterial Keratitis · EARLY_PHASE1 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT00029185 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Holles Laboratories, Inc.
Last refreshed: 24 March 2015

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00029185.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing